
### [MONDO:0019236](http://purl.obolibrary.org/obo/MONDO_0019236)
**Label:** disorder of purine metabolism

**Subclasses:** [MONDO:0018106](http://purl.obolibrary.org/obo/MONDO_0018106) (hereditary xanthinuria), [MONDO:0015253](http://purl.obolibrary.org/obo/MONDO_0015253) (Diamond-Blackfan anemia), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0010395](http://purl.obolibrary.org/obo/MONDO_0010395) (phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), 

**Corr. equiv. classes:** [Orphanet:45](http://www.orpha.net/ORDO/Orphanet_45), [Orphanet:124](http://www.orpha.net/ORDO/Orphanet_124), [Orphanet:99014](http://www.orpha.net/ORDO/Orphanet_99014), [OMIM:300661](http://purl.obolibrary.org/obo/OMIM_300661), [OMIM:308950](http://purl.obolibrary.org/obo/OMIM_308950), [OMIM:300322](http://purl.obolibrary.org/obo/OMIM_300322), [OMIM:311070](http://purl.obolibrary.org/obo/OMIM_311070), [OMIM:615511](http://purl.obolibrary.org/obo/OMIM_615511), [OMIM:612874](http://purl.obolibrary.org/obo/OMIM_612874), [Orphanet:3222](http://www.orpha.net/ORDO/Orphanet_3222), [OMIM:278300](http://purl.obolibrary.org/obo/OMIM_278300), [Orphanet:206428](http://www.orpha.net/ORDO/Orphanet_206428), [Orphanet:510](http://www.orpha.net/ORDO/Orphanet_510), [Orphanet:3467](http://www.orpha.net/ORDO/Orphanet_3467), [OMIM:603592](http://purl.obolibrary.org/obo/OMIM_603592), 

**Class expressions from DL-Learner:**

- [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 63.33%
- [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 63.33%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 63.33%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 63.33%
- [HP:0002149](http://purl.obolibrary.org/obo/HP_0002149) (Hyperuricemia) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 63.33%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0004368](http://purl.obolibrary.org/obo/HP_0004368) (Increased purine levels) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 63.33%


